Tumour Immunology and Anti-Cancer Immunotherapy Unit
Immunologie des Tumeurs et Immunothérapie Contre le Cancer

France

1 August 2019 - 31 July 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Tumour Immunology and Anti-Cancer Immunotherapy Unit published between 1 August 2019 - 31 July 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Tumour Immunology and Anti-Cancer Immunotherapy Unit is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

Count Share
8 0.33

Outputs by subject (Share)

Subject Count Share
Life Sciences 8 0.33

1 August 2019 - 31 July 2020

International vs. domestic collaboration by Share

  • 68.72% Domestic
  • 31.28% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by Share (68 total)

  • Tumour Immunology and Anti-Cancer Immunotherapy Unit, France
  • Domestic institution
  1. Cordelier Research Center (CRC), France (0.71)
    0.27
    0.45
  2. Assistance Publique-Hôpitaux de Paris (AP-HP), France (0.62)
    0.29
    0.33
  3. University of Paris, France (0.57)
    0.28
    0.29
  4. Ligue Contre Le Cancer, France (0.56)
    0.27
    0.29
  5. Centre Léon Bérard (CLB), France (0.51)
    0.02
    0.50
  6. Sorbonne University, France (0.46)
    0.29
    0.17
  7. Curie Institute, France (0.42)
    0.28
    0.13
  8. Center of Clinical Investigations in Biotherapies of Cancer (CICBT), France (0.36)
    0.23
    0.14
  9. French National Centre for Scientific Research (CNRS), France (0.36)
    0.21
    0.15
  10. École Pratique des Hautes Études (EPHE), France (0.35)
    0.27
    0.09

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Participating institutions

Tumour Immunology and Anti-Cancer Immunotherapy Unit is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Return to institution outputs